Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
IMIQUIMOD cream 50mg/g
BRIGHT MINDS BIOSCIENCES INC.
Cutaneous Lupus Erythematosus
1 trial -
Intravenous Nicotine
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
1 trial -
Low strength nicotine e-liquid
BRIGHT MINDS BIOSCIENCES INC.
Electronic Cigarette Use
1 trial -
Low-fat milk group
BRIGHT MINDS BIOSCIENCES INC.
Metabolic Syndrome
1 trial -
MDA
BRIGHT MINDS BIOSCIENCES INC.
Healthy
1 trial -
Mango
BRIGHT MINDS BIOSCIENCES INC.
Overweight or Obesity
1 trial -
Medication for opioid-use disorder (MOUD) for opioid-use disorder (OUD)
BRIGHT MINDS BIOSCIENCES INC.
HIV Infections
1 trial -
Methylphenidate HCl ER tablets 1
BRIGHT MINDS BIOSCIENCES INC.
Attention Deficit Hyperactivity Disorder
1 trial -
Morphine
BRIGHT MINDS BIOSCIENCES INC.
Sleep Deprivation
1 trial -
Multivitamins
BRIGHT MINDS BIOSCIENCES INC.
HIV Infections
1 trial -
Naltrexone and 2-butanol
BRIGHT MINDS BIOSCIENCES INC.
Healthy Adults
1 trial -
Nicotine
BRIGHT MINDS BIOSCIENCES INC.
Smoking
1 trial -
Nicotine Patch
BRIGHT MINDS BIOSCIENCES INC.
Major Depressive Disorder
1 trial -
Nicotine Replacement
BRIGHT MINDS BIOSCIENCES INC.
Cigarette Smoking-Related Carcinoma
2 trials -
Nicotine Replacement Therapy (Habitrol)
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
1 trial -
Nicotine Replacement Treatment (NRT)
BRIGHT MINDS BIOSCIENCES INC.
Substance Abuse
1 trial -
Nicotine patch
BRIGHT MINDS BIOSCIENCES INC.
Tobacco Use
1 trial -
Nicotine pod
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Addiction
1 trial -
Nut group
BRIGHT MINDS BIOSCIENCES INC.
Metabolic Syndrome
1 trial -
Ondansetron
BRIGHT MINDS BIOSCIENCES INC.
Opioid Withdrawal
1 trial -
Open Placebo
BRIGHT MINDS BIOSCIENCES INC.
Acute Pain
1 trial -
Oxytocin
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
1 trial -
Paroxetine
BRIGHT MINDS BIOSCIENCES INC.
Tobacco Use Disorder
1 trial -
Placebo
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
2 trials
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources